Beranda › Limfoma Sel B
Uji klinis Limfoma Sel B yang merekrut di AS
67 studi untuk Limfoma Sel B merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY19 studi
- Houston, TX16 studi
- Chicago, IL12 studi
- Philadelphia, PA11 studi
- Nashville, TN11 studi
- Rochester, MN10 studi
- Baldwin Park, CA9 studi
- Milwaukee, WI9 studi
- Cleveland, OH9 studi
- Boston, MA8 studi
- Salt Lake City, UT8 studi
- Pittsburgh, PA7 studi
- Columbus, OH7 studi
- Charlotte, NC7 studi
- Denver, CO7 studi
- Washington, DC7 studi
- Seattle, WA7 studi
- Dallas, TX7 studi
- New Haven, CT6 studi
- Edison, NJ6 studi
- Los Angeles, CA6 studi
- Atlanta, GA6 studi
- Aurora, CO6 studi
- San Antonio, TX6 studi
- Ann Arbor, MI5 studi
- Portland, OR5 studi
- Kansas City, MO5 studi
- Omaha, NE5 studi
- Mountain View, CA5 studi
- St. Louis, MO5 studi
- Louisville, KY4 studi
- Richmond, VA4 studi
- Tampa, FL4 studi
- Jacksonville, FL4 studi
- Cedar Rapids, IA4 studi
- Winston-Salem, NC4 studi
- Cincinnati, OH4 studi
- Miami, FL4 studi
- Indianapolis, IN4 studi
- Clifton, NJ3 studi
Berdasarkan negara bagian
- Arizona5 studi
- California20 studi
- Colorado11 studi
- Connecticut6 studi
- Distrik Columbia3 studi
- Florida15 studi
- Georgia8 studi
- Illinois12 studi
- Indiana5 studi
- Iowa6 studi
- Kansas9 studi
- Kentucky4 studi
- Maryland7 studi
- Massachusetts8 studi
- Michigan7 studi
- Minnesota12 studi
- Missouri5 studi
- Nebraska5 studi
- New Jersey9 studi
- New York21 studi
- North Carolina11 studi
- Ohio17 studi
- Oregon6 studi
- Pennsylvania16 studi
- Tennessee13 studi
- Texas26 studi
- Utah8 studi
- Virginia8 studi
- Washington10 studi
- Wisconsin10 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
Usia 0 hingga 38 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06131801T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06343311CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Menerima pesertaFase 1/2
Usia 3 hingga 39 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05442515Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06350318A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07439653A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06742996Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Menerima pesertaFase 2
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06052826A Study of Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06213311A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07101328A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05615636A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Menerima pesertaFase 1
Usia 0 hingga 18 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06173518UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
Menerima pesertaFase 1/2
31 Days – 30 Years · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT04544592Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06526793A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06634589Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05272384Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07225439A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06564038A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06393738Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Menerima pesertaStudi observasional
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07652580Study of NX-5948 Versus Pirtobrutinib in R/R CLL/SLL
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07516093A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07123454Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Agu 2026 · NCT07520006A Study of ARC-02 in B-cell NHL
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07691606Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05826535Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT05389423Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.